Ubs Group Ag Pro Mis Neurosciences Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	SELL	$1.28 - $2.81 $7,265 - $15,949	-5,676 Reduced 95.78%	250 $0
Q4 2023 Feb 09, 2024	BUY	$0.97 - $2.0 $5,648 - $11,646	5,823 Added 5653.4%	5,926 $6,000
Q3 2023 Nov 09, 2023	SELL	$1.52 - $6.19 $913 - $3,720	-601 Reduced 85.37%	103 $0
Q2 2023 Aug 11, 2023	BUY	$3.7 - $8.14 $2,604 - $5,730	704 New	704 $2,000
Q4 2022 Feb 08, 2023	SELL	$4.33 - $6.29 $2,459 - $3,572	-568 Reduced 19.51%	2,344 $10,000
Q3 2022 Nov 10, 2022	BUY	$4.99 - $9.25 $14,530 - $26,936	2,912 New	2,912 $18,000

Others Institutions Holding PMN

# of Institutions

17

Shares Held

3.26M

Call Options Held

0

Put Options Held

0

About ProMIS Neurosciences Inc.

Ticker PMN
Exchange OTC
Description
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.